Success Metrics

Clinical Success Rate

100.0%

Based on 8 completed trials

Completion Rate

100%(8/8)

Active Trials

0(0%)

Results Posted

38%(3 trials)

Phase Distribution

Ph phase_2

13%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 3Large-scale testing

2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (33.3%)

Phase 32 (66.7%)

Trials by Status

completed8100%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_3

Mirena Extension Trial

NCT02985541

completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea

NCT02475356

completed

Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion

NCT01958684

completedphase_2

Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

NCT00185380

completed

Mirena in Idiopathic Menorrhagia

NCT00868153

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT02985541Phase 3

Mirena Extension Trial

Completed

NCT02475356

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea

Completed

NCT01958684

Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion

Completed

NCT00185380Phase 2

Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

Completed

NCT00868153

Mirena in Idiopathic Menorrhagia

Completed

NCT01414140

Mirena Post-marketing Surveillance in Japan

Completed

NCT00931827

Acceptability of Long-term Progestin-only Contraception in Europe

Completed

NCT00360490Phase 3

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8